CK Life Sciences’ Sequencio Therapeutics Presents the Latest Vaccine Research Advancements at the American Association for Cancer Research Annual Meeting
- Written by The Bulletin
HONG KONG SAR - Media OutReach Newswire - 31 March 2026 - Sequencio Therapeutics Company Limited ("Sequencio"), a subsidiary of CK Life Sciences Int'l., (Holdings) Inc. ("CK Life Sciences"), today announced that five research abstracts will be presented at the American Association for Cancer Research ("AACR") Annual Meeting 2026, taking place 17–22 April 2026 in San Diego, USA.
